Home » Stocks » MIRO

Miromatrix Medical, Inc. (MIRO)

Miromatrix Medical will go public soon. The estimated IPO date is June 24, 2021.
Stock Price: $7.00 - $9.00
Current IPO price range
Market Cap 141.84M
Revenue (ttm) 41,550
Net Income (ttm) -7.79M
Shares Out 17.73M
EPS (ttm) -0.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Miromatrix Medical, Inc. has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About MIRO

Miromatrix Medical is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives. We have developed a proprietary perfusion technology platform for bioengineering organs that we believe will efficiently scale to address the shortage of available human organs. Our perfusion decellularization and recellularization technology platform includes 118 issued and 35 pending patent applications, with protection in the United States and major markets worldwide. Our... [Read more...]

Industry
Biological Products
IPO Date
Jun 24, 2021
CEO
Jeff Ross
Employees
36
Stock Exchange
NASDAQ
Ticker Symbol
MIRO
Full Company Profile

Financial Performance

In 2020, MIRO's revenue was $46,530, a decrease of -81.39% compared to the previous year's $250,000. Losses were -$10.31 million, 154.8% more than in 2019.

Financial Statements